Focal Therapeutics
1 known investors
Find your way into Focal Therapeutics
Focal Rx develops bioabsorbable medical devices, specifically the BioZorb 3D Bioabsorbable Marker, for clinical and surgical applications. The company operates in the medical device sector serving healthcare providers and patients.
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$48.9KraisedJan 2017 · 2 investors · Other Health CareRule 506(b)
▶$48.9KraisedJan 2017 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven NaberExecutive Officer
- Robert BrownellDirector
- Gail S. LebovicExecutive Officer, Director
- Steven GexExecutive Officer, Director
- Sharon StevensonDirector
- George D. HermannExecutive Officer, Director
- Offering amount
- $48.9K
- Amount sold
- $48.9K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.8MraisedMar 2016 · 28 investors · Other Health CareRule 506(b)
▶$3.8MraisedMar 2016 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gail S LebovicExecutive Officer, Director
- George D HermannExecutive Officer
- Robert BrownellDirector
- Steven GexExecutive Officer, Director
- Sharon StevensonDirector
- Steven NaberExecutive Officer
- Offering amount
- $5M
- Amount sold
- $3.8M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.8MraisedSep 2014 · 22 investors · Other Health CareRule 506(b)
▶$7.8MraisedSep 2014 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steven GexExecutive Officer, Director
- Robert BrownellDirector
- George D HermannExecutive Officer, Director
- Steven NaberExecutive Officer
- Sharon StevensonDirector
- Gail S LebovicDirector
- Offering amount
- $10.1M
- Amount sold
- $7.8M
- First sale
- Aug 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Focal Therapeutics do?
- Focal Rx develops bioabsorbable medical devices, specifically the BioZorb 3D Bioabsorbable Marker, for clinical and surgical applications. The company operates in the medical device sector serving healthcare providers and patients.
- Who are Focal Therapeutics's investors?
- Focal Therapeutics's investors include Emergent Medical Partners, LLP.